Effects of hypertension and exercise on cardiac proteome remodelling

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Petriz, Bernardo A ^a   Franco, Octavio L ^a  

^a UNIVERSIDADE CATÓLICA DE BRASÍLIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A ACYLTRANSFERASE; ALPHA ACTIN; ALPHA ENOLASE; ANGIOTENSIN II; ASPARTATE AMINOTRANSFERASE; ATRIAL NATRIURETIC FACTOR; BUTYRYL COENZYME A DEHYDROGENASE; ENDOTHELIN 1; FATTY ACID BINDING PROTEIN; FATTY ACID TRANSPORTER; GLUTATHIONE TRANSFERASE; HEAT SHOCK PROTEIN 20; MITOGEN ACTIVATED PROTEIN KINASE; MYOSIN HEAVY CHAIN BETA; MYOSIN LIGHT CHAIN 2; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLAMBAN; PROTEIN KINASE C; PROTEOME; PYRUVATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; THIOL ESTER HYDROLASE; TRANSCRIPTOME; TROPONIN I; MUSCLE PROTEIN;

AEROBIC EXERCISE; APOPTOSIS; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EXERCISE; EXERCISE INTENSITY; FATTY ACID OXIDATION; GENE MAPPING; HEART ARRHYTHMIA; HEART INFARCTION; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; NONHUMAN; PERINATAL PERIOD; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; PROTEOMICS; REPERFUSION INJURY; REVIEW; ANIMAL; HEART MUSCLE; METABOLISM; PATHOLOGY;

ANIMALS; EXERCISE; HUMANS; HYPERTENSION; MUSCLE PROTEINS; MYOCARDIUM; PROTEOME;

EID: 84901271726     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/634132     Document Type: Review

References (122)

1. WHO, A Global Brief on Hypertension 2013 World Health Organization
2. Norman M. K., Victor R. G., Clinical Hypertension 2010 10th Philadelphia, Pa, USA Lippincott Williams & Wilkins
3. Rosca M. G., Tandler B., Hoppel C. L., Mitochondria in cardiac hypertrophy and heart failure. Journal of Molecular and Cellular Cardiology 2013 55 31 41 10.1016/j.yjmcc.2012.09.002
4. Levy D., Larson M. G., Vasan R. S., Kannel W. B., Ho K. K. L., The progression from hypertension to congestive heart failure. The Journal of the American Medical Association 1996 275 20 1557 1562 2-s2.0-0030002580 10.1001/jama.275.20.1557 (Pubitemid 26154241)
5. Koivukoski L., Fisher S. A., Kanninen T., Lewis C. M., von Wowern F., Hunt S., Kardia S. L. R., Levy D., Perola M., Rankinen T., Rao D. C., Rice T., Thiel B. A., Melander O., Meta-analysis of genome-wide scans for hypertension and blood pressure in Caucasians shows evidence of susceptibility regions on chromosomes 2 and 3. Human Molecular Genetics 2004 13 19 2325 2332 2-s2.0-5444222846 10.1093/hmg/ddh237 (Pubitemid 39359929)
6. Kato N., Candidate genes revisited in the genetics of hypertension and blood pressure. Hypertension Research 2013 36 12 1032 1034 10.1038/hr.2013.89
7. Arnett D. K., Baird A. E., Barkley R. A., Basson C. T., Boerwinkle E., Ganesh S. K., Herrington D. M., Hong Y., Jaquish C., McDermott D. A., O'Donnell C. J., Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 2007 115 22 2878 2901 2-s2.0-34249906772 10.1161/CIRCULATIONAHA.107. 183679 (Pubitemid 46869676)
8. Veerasingham S. J., Sellers K. W., Raizada M. K., Functional genomics as an emerging strategy for the investigation of central mechanisms in experimental hypertension. Progress in Biophysics and Molecular Biology 2004 84 2-3 107 123 2-s2.0-0842328645 10.1016/j.pbiomolbio.2003.11.007 (Pubitemid 38215208)
9. Devereux R. B., Pickering T. G., Alderman M. H., Left ventricular hypertrophy in hypertension: prevalence and relationship to pathophysiologic variables. Hypertension 1987 9 2 II53 II60 2-s2.0-0023139649
10. Brilla C. G., Pick R., Tan L. B., Janicki J. S., Weber K. T., Remodeling of the rat right and left ventricles in experimental hypertension. Circulation Research 1990 67 6 1355 1364 2-s2.0-0025675680
11. Bernardo B. C., Weeks K. L., Pretorius L., McMullen J. R., Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacology & Therapeutics 2010 128 1 191 227 2-s2.0-78650121847 10.1016/j.pharmthera.2010.04. 005
12. Iemitsu M., Miyauchi T., Meda S., Sakai S., Fujii N., Miyazaki H., Kakinuma Y., Matsuda M., Yamaguchi I., Cardiac hypertrophy by hypertension and exercise training exhibits different gene expression of enzymes in energy metabolism. Hypertension Research 2003 26 10 829 837 2-s2.0-0242609903 10.1291/hypres.26.829 (Pubitemid 37406952)
13. Iemitsu M., Miyauchi T., Maeda S., Sakai S., Kobayashi T., Fujii N., Miyazaki H., Matsuda M., Yamaguchi I., Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat. American Journal of Physiology: Regulatory Integrative and Comparative Physiology 2001 281 6 R2029 R2036 2-s2.0-0035665581
14. Kemi O. J., Macquaide N., Hoydal M. A., Ellingsen O., Smith G. L., Wisloff U., Exercise training corrects control of spontaneous calcium waves in hearts from myocardial infarction heart failure rats. Journal of Cellular Physiology 2012 227 1 20 26 2-s2.0-80054879050 10.1002/jcp.22771
15. Carneiro-Júnior M. A., Pelúzio M. C. G., Silva C. H. O., Amorim P. R. S., Silva K. A., Souza M. O., Castro C. A., Roman-Campos D., Prímola-Gomes T. N., Natali A. J., Exercise training and detraining modify the morphological and mechanical properties of single cardiac myocytes obtained from spontaneously hypertensive rats. Brazilian Journal of Medical and Biological Research 2010 43 11 1042 1046 2-s2.0-78649457374 10.1590/S0100- 879X2010007500117
16. Chicco A. J., McCune S. A., Emter C. A., Sparagna G. C., Rees M. L., Bolden D. A., Marshall K. D., Murphy R. C., Moore R. L., Low-intensity exercise training delays heart failure and improves survival in female hypertensive heart failure rats. Hypertension 2008 51 4 1096 1102 2-s2.0-40849139513 10.1161/HYPERTENSIONAHA.107.107078 (Pubitemid 351398979)
17. Emter C. A., McCune S. A., Sparagna G. C., Radin M. J., Moore R. L., Low-intensity exercise training delays onset of decompensated heart failure in spontaneously hypertensive heart failure rats. American Journal of Physiology: Heart and Circulatory Physiology 2005 289 5 H2030 H2038 2-s2.0-27144491354 10.1152/ajpheart.00526.2005 (Pubitemid 41507354)
18. Boissiere J., Eder V., Machet M.-C., Courteix D., Bonnet P., Moderate exercise training does not worsen left ventricle remodeling and function in untreated severe hypertensive rats. Journal of Applied Physiology 2008 104 2 321 327 2-s2.0-38949209855 10.1152/japplphysiol.00442.2007 (Pubitemid 351231478)
19. Sliwa K., Stewart S., Gersh B. J., Hypertension: a global perspective. Circulation 2011 123 24 2892 2896 2-s2.0-79959509371 10.1161/CIRCULATIONAHA.110. 992362
20. Kurukulasuriya L. R., Stas S., Lastra G., Manrique C., Sowers J. R., Hypertension in obesity. Medical Clinics of North America 2011 95 5 903 917 2-s2.0-80051771011 10.1016/j.mcna.2011.06.004
21. Lim S. S., Vos T., Flaxman A. D., A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 2012 380 9859 2224 2260 10.1016/S0140-6736(12)61766-8
22. Delles C., McBride M. W., Graham D., Padmanabhan S., Dominiczak A. F., Genetics of hypertension: from experimental animals to humans. Biochimica et Biophysica Acta 2010 1802 12 1299 1308 10.1016/j.bbadis.2009.12.006
23. Newton-Cheh C., Johnson T., Gateva V., Genome-wide association study identifies eight loci associated with blood pressure. Nature Genetics 2009 41 6 666 676 10.1038/ng.361
24. Blinderman C. D., Homel P., Billings J. A., Portenoy R. K., Tennstedt S. L., Symptom distress and quality of life in patients with advanced congestive heart failure. Journal of Pain and Symptom Management 2008 35 6 594 603 2-s2.0-43949089166 10.1016/j.jpainsymman.2007.06.007 (Pubitemid 351707757)
25. Delles C., Neisius U., Carty D. M., Proteomics in hypertension and other cardiovascular diseases. Annals of Medicine 2012 44 supplement 1 S55 S64
26. Levy D., Garrison R. J., Savage D. D., Kannel W. B., Castelli W. P., Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. The New England Journal of Medicine 1990 322 22 1561 1566 2-s2.0-0025280867 (Pubitemid 20176696)
27. Schillaci G., Verdecchia P., Borgioni C., Ciucci A., Zampi I., Battistelli M., Gattobigio R., Sacchi N., Porcellati C., Association between persistent pressure overload and ventricular arrhythmias in essential hypertension. Hypertension 1996 28 2 284 289 2-s2.0-0029763041 (Pubitemid 26322803)
28. Eghbali M., Deva R., Alioua A., Minosyan T. Y., Ruan H., Wang Y., Toro L., Stefani E., Molecular and functional signature of heart hypertrophy during pregnancy. Circulation Research 2005 96 11 1208 1216 2-s2.0-20444494301 10.1161/01.RES.0000170652.71414.16 (Pubitemid 40827697)
29. Umar S., Nadadur R., Iorga A., Amjedi M., Matori H., Eghbali M., Cardiac structural and hemodynamic changes associated with physiological heart hypertrophy of pregnancy are reversed postpartum. Journal of Applied Physiology 2012 113 8 1253 1259 10.1152/japplphysiol.00549.2012
30. Radovits T., Oláh A., Lux Á., Rat model of exercise-induced cardiac hypertrophy: hemodynamic characterization using left ventricular pressure-volume analysis. American Journal of Physiology: Heart and Circulatory Physiology 2013 305 1 H124 H134 10.1152/ajpheart.00108.2013
31. Medford H. M., Porter K., Marsh S. A., Immediate effects of a single exercise bout on protein O -GlcNAcylation and chromatin regulation of cardiac hypertrophy. American Journal of Physiology: Heart and Circulatory Physiology 2013 305 1 H114 H123 10.1152/ajpheart.00135.2013
32. Rohini A., Agrawal N., Koyani C. N., Singh R., Molecular targets and regulators of cardiac hypertrophy. Pharmacological Research 2010 61 4 269 280 2-s2.0-77649342305 10.1016/j.phrs.2009.11.012
33. Fagard R. H., Impact of different sports and training on cardiac structure and function. Cardiology Clinics 1997 15 3 397 412 2-s2.0-0030828913 10.1016/S0733-8651(05)70348-9 (Pubitemid 27371584)
34. Li J., Umar S., Amjedi M., New frontiers in heart hypertrophy during pregnancy. American Journal of Cardiovascular Disease 2012 2 3 192 207
35. Yamamoto S., Kita S., Iyoda T., Yamada T., Iwamoto T., New molecular mechanisms for cardiovascular disease: cardiac hypertrophy and cell-volume regulation. Journal of Pharmacological Sciences 2011 116 4 343 349 2-s2.0-84860414917 10.1254/jphs.10R31FM
36. Thongboonkerd V., Klein J. B., Proteomics and hypertension. Contributions to Nephrology 2004 141 245 256 2-s2.0-15444368389
37. Thongboonkerd V., Genomics, proteomics and integrative "omics" in hypertension research. Current Opinion in Nephrology and Hypertension 2005 14 2 133 139 2-s2.0-15444368510 (Pubitemid 40396866)
38. Philip-Couderc P., Smih F., Pelat M., Vidal C., Verwaerde P., Pathak A., Buys S., Galinier M., Senard J.-M., Rouet P., Cardiac transcriptome analysis in obesity-related hypertension. Hypertension 2003 41 3 414 421 2-s2.0-0037338685 10.1161/01.HYP.0000057573.32425.95 (Pubitemid 36314610)
39. Jin X., Xia L., Wang L.-S., Shi J.-Z., Zheng Y., Chen W.-L., Zhang L., Liu Z.-G., Chen G.-Q., Fang N.-Y., Differential protein expression in hypertrophic heart with and without hypertension in spontaneously hypertensive rats. Proteomics 2006 6 6 1948 1956 2-s2.0-33645474310 10.1002/pmic.200500337
40. Jin X., Wang L.-S., Xia L., Zheng Y., Meng C., Yu Y., Chen G.-Q., Fang N.-Y., Hyper-phosphorylation of α -enolase in hypertrophied left ventricle of spontaneously hypertensive rat. Biochemical and Biophysical Research Communications 2008 371 4 804 809 2-s2.0-44149095214 10.1016/j.bbrc.2008.04.166
41. 1 receptor subtype. Circulation Research 1993 73 3 413 423 2-s2.0-0027182438 (Pubitemid 23238726)
42. Ménard J., Campbell D. J., Azizi M., Gonzales M.-F., Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats. Circulation 1997 96 9 3072 3078 2-s2.0-0342894669 10.1161/01.CIR.96.9.3072 (Pubitemid 27500110)
43. Casey T. M., Arthur P. G., Bogoyevitch M. A., Proteomic analysis reveals different protein changes during endothelin-1- or leukemic inhibitory factor-induced hypertrophy of cardiomyocytes in vitro. Molecular and Cellular Proteomics 2005 4 5 651 661 2-s2.0-20844444341 10.1074/mcp.M400155-MCP200 (Pubitemid 40862243)
44. Frohlich E. D., Risk mechanisms in hypertensive heart disease. Hypertension 1999 34 4 782 789 2-s2.0-0032729878 (Pubitemid 29501300)
45. Meng C., Jin X., Xia L., Shen S.-M., Wang X.-L., Cai J., Chen G.-Q., Wang L.-S., Fang N.-Y., Alterations of mitochondrial enzymes contribute to cardiac hypertrophy before hypertension development in spontaneously hypertensive rats. Journal of Proteome Research 2009 8 5 2463 2475 2-s2.0-66749100634 10.1021/pr801059u
46. Doggrell S. A., Brown L., Rat models of hypertension, cardiac hypertrophy and failure. Cardiovascular Research 1998 39 1 89 105 2-s2.0-0032127809 10.1016/S0008-6363(98)00076-5 (Pubitemid 28322382)
47. Boknik P., Heinroth-Hoffmann I., Kirchhefer U., Enhanced protein phosphorylation in hypertensive hypertrophy. Cardiovascular Research 2001 51 4 717 728 10.1016/S0008-6363(01)00346-7 (Pubitemid 32800713)
48. Allard M. F., Energy substrate metabolism in cardiac hypertrophy. Current Hypertension Reports 2004 6 6 430 435 2-s2.0-10044249835 (Pubitemid 39600098)
49. Zhou S.-G., Zhou S.-F., Huang H.-Q., Chen J.-W., Huang M., Liu P.-Q., Proteomic analysis of hypertrophied myocardial protein patterns in renovascularly hypertensive and spontaneously hypertensive rats. Journal of Proteome Research 2006 5 11 2901 2908 2-s2.0-33751015099 10.1021/pr050456l (Pubitemid 44749208)
50. Gallego-Delgado J., Lazaro A., Osende J. I., Barderas M. G., Duran M. C., Vivanco F., Egido J., Comparison of the protein profile of established and regressed hypertension-induced left ventricular hypertrophy. Journal of Proteome Research 2006 5 2 404 413 2-s2.0-32344434179 10.1021/pr0503275 (Pubitemid 43222309)
51. + channel knockout induces cardiac proteome remodeling predictive of heart disease susceptibility. Journal of Proteome Research 2009 8 10 4823 4834 2-s2.0-70349972372 10.1021/pr900561g
52. Arrell D. K., Lindor J. Z., Yamada S., Terzic A., K ATP channel-dependent metaboproteome decoded: systems approaches to heart failure prediction, diagnosis, and therapy. Cardiovascular Research 2011 90 2 258 266 2-s2.0-79955444666 10.1093/cvr/cvr046
53. Zlatkovic J., Arrell D. K., Kane G. C., Miki T., Seino S., Terzic A., Proteomic profiling of KATP channel-deficient hypertensive heart maps risk for maladaptive cardiomyopathic outcome. Proteomics 2009 9 5 1314 1325 2-s2.0-63049104538 10.1002/pmic.200800718
54. Yuan F., Brandt N. R., Pinto J. M. B., Wasserlauf B. J., Myerburg R. J., Bassett A. L., Hypertrophy decreases cardiac KATP channel responsiveness to exogenous and locally generated (glycolytic) ATP. Journal of Molecular and Cellular Cardiology 1997 29 10 2837 2848 2-s2.0-0031258528 10.1006/jmcc.1997. 0518 (Pubitemid 27466505)
55. Hu X., Xu X., Huang Y., Fassett J., Flagg T. P., Zhang Y., Nichols C. G., Bache R. J., Chen Y., Disruption of sarcolemmal atp-sensitive potassium channel activity impairs the cardiac response to systolic overload. Circulation Research 2008 103 9 1009 1017 2-s2.0-55449134162 10.1161/CIRCRESAHA.107.170795
56. Kane G. C., Liu X.-K., Yamada S., Olson T. M., Terzic A., Cardiac KATP channels in health and disease. Journal of Molecular and Cellular Cardiology 2005 38 6 937 943 2-s2.0-19444367728 10.1016/j.yjmcc.2005.02.026 (Pubitemid 40725941)
57. Shimomura T., Miyazawa K., Komiyama Y., Hiraoka H., Naka D., Morimoto Y., Kitamura N., Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator. European Journal of Biochemistry 1995 229 1 257 261 2-s2.0-0028912994 10.1111/j.1432-1033.1995.tb20463.x
58. Meneton P., Bloch-Faure M., Hagege A. A., Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 2001 98 5 2634 2639 10.1073/pnas.051619598 (Pubitemid 32209534)
59. Klingler D., Hardt M., Targeting proteases in cardiovascular diseases by mass spectrometry-based proteomics. Circulation: Cardiovascular Genetics 2012 5 2, article 265 10.1161/CIRCGENETICS.110.957811
60. Rogers L., Overall C. M., Proteolytic post translational modification of proteins: proteomic tools and methodology. Molecular & Cellular Proteomics 2013 12 12 3532 3542 10.1074/mcp.M113.031310
61. Petriz B. A., de Almeida J. A., Migliolo L., Franco O. L., Pharmacological potential of exercise and RAS vasoactive peptides for prevention of diseases. Current Protein & Peptide Science 2013 14 6 459 471 10.2174/13892037113149990063
62. Paul M., Mehr A. P., Kreutz R., Physiology of local renin-angiotensin systems. Physiological Reviews 2006 86 3 747 803 2-s2.0-33745845825 10.1152/physrev.00036.2005 (Pubitemid 44033382)
63. Kim S., Ohta K., Hamaguchi A., Yukimura T., Miura K., Iwao H., Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats. Hypertension 1995 25 6 1252 1259 2-s2.0-0029006679
64. Baker K. M., Aceto J. F., Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. American Journal of Physiology: Heart and Circulatory Physiology 1990 259 2 H610 H618 2-s2.0-0025126437 (Pubitemid 20259440)
65. Sadoshima J.-I., Malhotra R., Izumo S., The role of the cardiac renin-angiotensin system in load-induced cardiac hypertrophy. Journal of Cardiac Failure 1996 2 supplement 4 S1 S6 2-s2.0-0030331084 (Pubitemid 126686384)
66. Childs T. J., Adams M. A., Mak A. S., Regression of cardiac hypertrophy in spontaneously hypertensive rats by enalapril and the expression of contractile proteins. Hypertension 1990 16 6 662 668 2-s2.0-0025641804
67. 1 receptor dimerization. Cardiovascular Research 2008 79 1 169 178 10.1093/cvr/cvn064 (Pubitemid 351881932)
68. Thomas W. G., Brandenburger Y., Autelitano D. J., Pham T., Qian H., Hannan R. D., Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor. Circulation Research 2002 90 2 135 142 2-s2.0-0037040165 10.1161/hh0202.104109 (Pubitemid 34627081)
69. Finckenberg P., Eriksson O., Baumann M., Merasto S., Lalowski M. M., Levijoki J., Haasio K., Kytö V., Muller D. N., Luft F. C., Oresic M., Mervaala E., Caloric restriction ameliorates angiotensin II-induced mitochondrial remodeling and cardiac hypertrophy. Hypertension 2012 59 1 76 84 2-s2.0-83655167120 10.1161/HYPERTENSIONAHA.111.179457
70. Mervaala E., Biala A., Merasto S., Lempiäinen J., Mattila I., Martonen E., Eriksson O., Louhelainen M., Finckenberg P., Kaheinen P., Muller D. N., Luft F. C., Lapatto R., Oresic M., Metabolomics in angiotensin II-induced cardiac hypertrophy. Hypertension 2010 55 2 508 515 2-s2.0-74949138093 10.1161/HYPERTENSIONAHA.109.145490
71. Bugger H., Schwarzer M., Chen D., Schrepper A., Amorim P. A., Schoepe M., Nguyen T. D., Mohr F. W., Khalimonchuk O., Weimer B. C., Doenst T., Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure. Cardiovascular Research 2010 85 2 376 384 2-s2.0-72949110566 10.1093/cvr/cvp344
72. Wellner M., Dechend R., Park J.-K., Shagdarsuren E., Al-Saadi N., Kirsch T., Gratze P., Schneider W., Meiners S., Fiebeler A., Haller H., Luft F. C., Muller D. N., Cardiac gene expression profile in rats with terminal heart failure and cachexia. Physiological Genomics 2005 20 3 256 267 2-s2.0-20144367075 10.1152/physiolgenomics.00165.2004 (Pubitemid 40388525)
73. Gucek M., Murphy E., What can we learn about cardioprotection from the cardiac mitochondrial proteome? Cardiovascular Research 2010 88 2 211 218 2-s2.0-77956586703 10.1093/cvr/cvq277
74. Ritchie R. H., Delbridge L. M. D., Cardiac hypertrophy, substrate utilization and metabolic remodelling: cause or effect? Clinical and Experimental Pharmacology and Physiology 2006 33 1-2 159 166 2-s2.0-33645076024 10.1111/j.1440-1681.2006.04342.x
75. Seddon M., Looi Y. H., Shah A. M., Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 2007 93 8 903 907 2-s2.0-34547185623 10.1136/hrt.2005.068270 (Pubitemid 47122034)
76. Postnov Y. V., Orlov S. N., Budnikov Y. Y., Doroschuk A. D., Postnov A. Y., Mitochondrial energy conversion disturbance with decrease in ATP production as a source of systemic arterial hypertension. Pathophysiology 2007 14 3 195 204 2-s2.0-36448965941 10.1016/j.pathophys.2007.09.002 (Pubitemid 350166885)
77. Bupha-Intr T., Haizlip K. M., Janssen P. M., Role of endothelin in the induction of cardiac hypertrophy in vitro. PLoS ONE 2012 7 8 e43179 10.1371/journal.pone.0043179
78. Yamazaki T., Kurihara H., Kurihara Y., Komuro I., Yazaki Y., Endothelin-1 regulates normal cardiovascular development and cardiac cellular hypertrophy. Journal of Cardiac Failure 1996 2 supplement 1 S7 S12 2-s2.0-0030338385 (Pubitemid 126686385)
79. Agnetti G., Bezstarosti K., Dekkers D. H. W., Verhoeven A. J. M., Giordano E., Guarnieri C., Caldarera C. M., Van Eyk J. E., Lamers J. M. J., Proteomic profiling of endothelin-1-stimulated hypertrophic cardiomyocytes reveals the increase of four different desmin species and α -B-crystallin. Biochimica et Biophysica Acta 2008 1784 7-8 1068 1076 2-s2.0-52449135472 10.1016/j.bbapap.2008.04.003
80. Chowdhury D., Tangutur A. D., Khatua T. N., Saxena P., Banerjee2 S. K., Bhadra M. P., A proteomic view of isoproterenol induced cardiac hypertrophy: prohibitin identified as a potential biomarker in rats. Journal of Translational Medicine 2013 11, article 130 10.1186/1479-5876-11-130
81. Molojavyi A., Lindecke A., Raupach A., Moellendorf S., Köhrer K., Gödecke A., Myoglobin-deficient mice activate a distinct cardiac gene expression program in response to isoproterenol-induced hypertrophy. Physiological Genomics 2010 41 2 137 145 2-s2.0-77951152823 10.1152/ physiolgenomics.90297.2008
82. Zhang J., Guy M. J., Norman H. S., Chen Y.-C., Xu Q., Dong X., Guner H., Wang S., Kohmoto T., Young K. H., Moss R. L., Ge Y., Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure. Journal of Proteome Research 2011 10 9 4054 4065 2-s2.0-80052438941 10.1021/pr200258m
83. Kuznetsova T., Mischak H., Mullen W., Staessen J. A., Urinary proteome analysis in hypertensive patients with left ventricular diastolic dysfunction. European Heart Journal 2012 33 18 2342 2350 10.1093/eurheartj/ehs185
84. Ares-Carrasco S., Picatoste B., Camafeita E., Carrasco-Navarro S., Zubiri I., Ortiz A., Egido J., López J. A., Tuñón J., Lorenzo O., Proteome changes in the myocardium of experimental chronic diabetes and hypertension: role of PPAR α in the associated hypertrophy. Journal of Proteomics 2012 75 6 1816 1829 2-s2.0-84857653408 10.1016/j.jprot.2011.12.023
85. Naaby-Hansen S., Warnasuriya G. D., Hastie C., Gallney P., Cramer R., Proteomic approaches in the analysis of hypertension. Methods in Molecular Medicine 2005 108 275 296 2-s2.0-24644483119
86. Carty D. M., Schiffer E., Delles C., Proteomics in hypertension. Journal of Human Hypertension 2013 27 4 211 216 10.1038/jhh.2012.30
87. Thongboonkerd V., Gozal E., Sachleben L. R. Jr., Arthur J. M., Pierce W. M., Cai J., Chao J., Bader M., Pesquero J. B., Gozal D., Klein J. B., Proteomic analysis reveals alterations in the renal kallikrein pathway during hypoxia-induced hypertension. The Journal of Biological Chemistry 2002 277 38 34708 34716 2-s2.0-0037144575 10.1074/jbc.M203799200
88. Pinet F., Poirier F., Fuchs S., Tharaux P.-L., Caron M., Corvol P., Michel J.-B., Joubert-Caron R., Troponin T as a marker of differentiation revealed by proteomic analysis in renal arterioles. The FASEB Journal 2004 18 3 585 586 2-s2.0-2442693174
89. Aregger F., Uehlinger D. E., Witowski J., Brunisholz R. A., Hunziker P., Frey F. J., Jörres A., Identification of IGFBP-7 by urinary proteomics as a novel prognostic marker in early acute kidney injury. Kidney International 2014 85 4 909 919 10.1038/ki.2013.363
90. Chen G., Zhang Y., Jin X., Zhang L., Zhou Y., Niu J., Chen J., Gu Y., Urinary proteomics analysis for renal injury in hypertensive disorders of pregnancy with iTRAQ labeling and LC-MS/MS. Proteomics: Clinical Applications 2011 5 5-6 300 310 2-s2.0-79957751483 10.1002/prca.201000100
91. Carty D. M., Siwy J., Brennand J. E., Urinary proteomics for prediction of preeclampsia. Hypertension 2011 57 3 561 569 10.1161/HYPERTENSIONAHA.110. 164285
92. Rossing K., Mischak H., Dakna M., Urinary proteomics in diabetes and CKD. Journal of the American Society of Nephrology 2008 19 7 1283 1290 10.1681/ASN.2007091025
93. Gebhard S., Steil L., Peters B., Gesell-Salazar M., Hammer E., Kuttler B., Clemetson K. J., Scharf C., Peters J., Völker U., Rettig R., Greinacher A., Angiotensin II-dependent hypertension causes reversible changes in the platelet proteome. Journal of Hypertension 2011 29 11 2126 2137 2-s2.0-80054104931 10.1097/HJH.0b013e32834b1991
94. Burniston J. G., Hoffman E. P., Proteomic responses of skeletal and cardiac muscle to exercise. Expert Review of Proteomics 2011 8 3 361 377 2-s2.0-79959438797 10.1586/epr.11.17
95. Petriz B. A., Gomes C. P., Rocha L. A. O., Rezende T. M. B., Franco O. L., Proteomics applied to exercise physiology: a cutting-edge technology. Journal of Cellular Physiology 2012 227 3 885 898 2-s2.0-84155192359 10.1002/jcp.22809
96. Bansal A., Dai Q., Chiao Y. A., Hakala K. W., Zhang J. Q., Weintraub S. T., Lindsey M. L., Proteomic analysis reveals late exercise effects on cardiac remodeling following myocardial infarction. Journal of Proteomics 2010 73 10 2041 2049 2-s2.0-77956396754 10.1016/j.jprot.2010.06.009
97. Boluyt M. O., Brevick J. L., Rogers D. S., Randall M. J., Scalia A. F., Li Z. B., Changes in the rat heart proteome induced by exercise training: increased abundance of heat shock protein hsp20. Proteomics 2006 6 10 3154 3169 2-s2.0-33744471646 10.1002/pmic.200401356 (Pubitemid 43806411)
98. Burniston J. G., Adaptation of the rat cardiac proteome in response to intensity-controlled endurance exercise. Proteomics 2009 9 1 106 115 2-s2.0-59449104541 10.1002/pmic.200800268
99. Kavazis A. N., Alvarez S., Talbert E., Lee Y., Powers S. K., Exercise training induces a cardioprotective phenotype and alterations in cardiac subsarcolemmal and intermyofibrillar mitochondrial proteins. American Journal of Physiology: Heart and Circulatory Physiology 2009 297 1 H144 H152 2-s2.0-67650078249 10.1152/ajpheart.01278.2008
100. Petriz B. A., Cunha V. N., Villeth G. R., Effects of acute exercise over heart proteome from monogenic obese (ob/ob) mice. Journal of Cellular Physiology 2013 228 4 824 834 10.1002/jcp.24231
101. Rocha L. A., Petriz B. A., Borges D. H., High molecular mass proteomics analyses of left ventricle from rats subjected to differential swimming training. BMC Physiology 2012 12, article 11 10.1186/1472-6793-12-11
102. Sun B., Wang J. H., Lv Y. Y., Zhu S. S., Yang J., Ma J. Z., Proteomic adaptation to chronic high intensity swimming training in the rat heart. Comparative Biochemistry and Physiology D: Genomics and Proteomics 2008 3 1 108 117 2-s2.0-39149130661 10.1016/j.cbd.2007.11.001 (Pubitemid 351250862)
103. Lakka T. A., Venäläinen J. M., Rauramaa R., Salonen R., Tuomilehto J., Salonen J. T., Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction in men. The New England Journal of Medicine 1994 330 22 1549 1554 2-s2.0-0028217629 10.1056/NEJM199406023302201 (Pubitemid 24160957)
104. Knight J. A., Physical inactivity: associated diseases and disorders. Annals of Clinical & Laboratory Science 2012 42 3 320 337
105. Schlüter K.-D., Schreckenberg R., Rebelo R. M. C., Interaction between exercise and hypertension in spontaneously hypertensive rats: a meta-analysis of experimental studies. Hypertension Research 2010 33 11 1155 1161 2-s2.0-78149290363 10.1038/hr.2010.155
106. Kemi O. J., Haram P. M., Loennechen J. P., Osnes J.-B., Skomedal T., Wisløff U., Ellingsen Ø., Moderate vs. high exercise intensity: differential effects on aerobic fitness, cardiomyocyte contractility, and endothelial function. Cardiovascular Research 2005 67 1 161 172 2-s2.0-20444368017 10.1016/j.cardiores.2005.03.010 (Pubitemid 40798303)
107. Libonati J. R., Sabri A., Xiao C., MacDonnell S. M., Renn B. F., Exercise training improves systolic function in hypertensive myocardium. Journal of Applied Physiology 2011 111 6 1637 1643 2-s2.0-83655165354 10.1152/japplphysiol. 00292.2011
108. Horta P. P., de Carvalho J. J., Mandarim-de-Lacerda C. A., Exercise training attenuates blood pressure elevation and adverse remodeling in the aorta of spontaneously hypertensive rats. Life Sciences 2005 77 26 3336 3343 2-s2.0-26444549354 10.1016/j.lfs.2005.05.044 (Pubitemid 41435103)
109. Kolwicz S. C., MacDonnell S. M., Renna B. F., Left ventricular remodeling with exercise in hypertension. American Journal of Physiology: Heart and Circulatory Physiology 2009 297 4 H1361 H1368 10.1152/ajpheart.01253.2008
110. Peterson J. M., Bryner R. W., Sindler A., Frisbee J. C., Alway S. E., Mitochondrial apoptotic signaling is elevated in cardiac but not skeletal muscle in the obese Zucker rat and is reduced with aerobic exercise. Journal of Applied Physiology 2008 105 6 1934 1943 2-s2.0-57349129372 10.1152/japplphysiol. 00037.2008
111. Rebelo R. M. C., Schreckenberg R., Schluter K. D., Adverse cardiac remodelling in spontaneously hypertensive rats: acceleration by high aerobic exercise intensity. The Journal of Physiology 2012 590 21 5389 5400 10.1113/jphysiol.2012.241141
112. Burniston J. G., Kenyani J., Wastling J. M., Burant C. F., Qi N. R., Koch L. G., Britton S. L., Proteomic analysis reveals perturbed energy metabolism and elevated oxidative stress in hearts of rats with inborn low aerobic capacity. Proteomics 2011 11 16 3369 3379 2-s2.0-79960759435 10.1002/pmic.201000593
113. Kaludercic N., Carpi A., Menabò R., di Lisa F., Paolocci N., Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury. Biochimica et Biophysica Acta 2011 1813 7 1323 1332 2-s2.0-79957936379 10.1016/j.bbamcr.2010.09.010
114. Kaludercic N., Takimoto E., Nagayama T., Feng N., Lai E. W., Bedja D., Chen K., Gabrielson K. L., Blakely R. D., Shih J. C., Pacak K., Kass D. A., di Lisa F., Paolocci N., Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload. Circulation Research 2010 106 1 193 202 2-s2.0-74049129002 10.1161/CIRCRESAHA.109.198366
115. Jing L., Parker C. E., Seo D., Hines M. W., Dicheva N., Yu Y., Schwinn D., Ginsburg G. S., Chen X., Discovery of biomarker candidates for coronary artery disease from an APOE-knock out mouse model using iTRAQ-based multiplex quantitative proteomics. Proteomics 2011 11 14 2763 2776 2-s2.0-79959757195 10.1002/pmic.201000202
116. Warren C. M., Geenen D. L., Helseth D. L. Jr., Xu H., Solaro R. J., Sub-proteomic fractionation, iTRAQ, and OFFGEL-LC-MS/MS approaches to cardiac proteomics. Journal of Proteomics 2010 73 8 1551 1561 2-s2.0-77953121217 10.1016/j.jprot.2010.03.016
117. Köcher T., Pichler P., Schutzbier M., Stingl C., Kaul A., Teucher N., Hasenfuss G., Penninger J. M., Mechtler K., High precision quantitative proteomics using iTRAQ on an LTQ Orbitrap: a new mass spectrometric method combining the benefits of all. Journal of Proteome Research 2009 8 10 4743 4752 2-s2.0-70349974261 10.1021/pr900451u
118. Hamilton K. L., Antioxidants and cardioprotection. Medicine & Science in Sports & Exercise 2007 39 9 1544 1553 2-s2.0-34548463341 10.1249/mss.0b013e3180d099e8 (Pubitemid 47360978)
119. Fan G.-C., Chu G., Kranias E. G., Hsp20 and its cardioprotection. Trends in Cardiovascular Medicine 2005 15 4 138 141 2-s2.0-23744486082 10.1016/j.tcm.2005.05.004 (Pubitemid 41138877)
120. Fan G.-C., Chu G., Mitton B., Song Q., Yuan Q., Kranias E. G., Small heat-shock protein Hsp20 phosphorylation inhibits β -agonist-induced cardiac apoptosis. Circulation Research 2004 94 11 1474 1482 2-s2.0-2942689980 10.1161/01.RES.0000129179.66631.00 (Pubitemid 38780320)
121. Qian J., Ren X., Wang X., Zhang P., Jones W. K., Molkentin J. D., Fan G.-C., Kranias E. G., Blockade of Hsp20 phosphorylation exacerbates cardiac ischemia/reperfusion injury by suppressed autophagy and increased cell death. Circulation Research 2009 105 12 1223 1231 2-s2.0-73349134699 10.1161/CIRCRESAHA.109.200378
122. Low T. Y., van Heesch S., van den Toorn H., Quantitative and qualitative proteome characteristics extracted from in-depth integrated genomics and proteomics analysis. Cell Reports 2013 5 5 1469 1478 10.1016/j.celrep.2013.10. 041 Nível Superior